TNK2/ACK1-mediated phosphorylation of ATP5F1A (ATP synthase F1 subunit alpha) selectively augments survival of

Surbhi Chouhan1,2, Mithila Sawant1,2, Cody Weimholt3

  • 1Department of Surgery, Cancer Research Building, St. Louis, MO, USA.

Autophagy
|July 27, 2022
PubMed

Insights

Cancer cells exploit tyrosine kinase TNK2/ACK1 to boost mitochondrial energy production by phosphorylating ATP synthase. Inhibiting TNK2 triggers mitophagy, reducing tumor growth and offering a new cancer therapy strategy.

Area of Science:

  • Biochemistry
  • Cancer Biology
  • Mitochondrial Metabolism

Background:

  • Cancer cells require high energy due to rapid macromolecular synthesis, necessitating metabolic adaptations.
  • Oncogenic tyrosine kinases are activated in cancer, but their direct role in meeting cancer cell mitochondrial energy demands is unclear.
  • Mitochondrial function and metabolic reprogramming are critical for cancer cell survival and proliferation.

Purpose of the Study:

  • To elucidate the mechanism by which tyrosine kinase activity directly enhances mitochondrial energy output in cancer cells.
  • To investigate the role of TNK2/ACK1 in regulating ATP synthase stability and activity.
  • To evaluate the therapeutic potential of targeting TNK2 for cancer treatment, specifically inducing mitophagy.

Main Methods:

  • Phosphorylation analysis of ATP synthase F1 subunit alpha (ATP5F1A) by TNK2/ACK1.
  • Assessment of Complex V stability and mitochondrial energy output in cancer cells.
  • Treatment with a TNK2 inhibitor ((R)-9b) and evaluation of its effects on mitophagy, tumor growth, and p-Y-ATP5F1A levels.
  • Analysis of Tnk2 transgenic mice and human prostate cancer progression.

Main Results:

  • TNK2/ACK1 phosphorylates ATP5F1A at Tyr243 and Tyr246, increasing Complex V stability and mitochondrial energy output.
  • Phospho-ATP5F1A (p-Y-ATP5F1A) inhibits binding to ATP5IF1, sustaining mitochondrial activity and promoting cancer growth.
  • The TNK2 inhibitor (R)-9b reverses these effects, inducing mitophagy and reducing prostate tumor growth while sparing normal cells.
  • Depletion of p-Y-ATP5F1A is essential for (R)-9b-mediated mitophagy and tumor suppression.
  • Tnk2 overexpression in mice leads to increased p-Y-ATP5F1A, reduced mitophagy, and prostatic intraepithelial neoplasia (PINs).
  • Elevated p-Y-ATP5F1A correlates with prostate cancer progression.

Conclusions:

  • Tyrosine kinase-mediated regulation of mitochondrial energy production represents a vulnerability in cancer cells.
  • TNK2/ACK1 plays a crucial role in enhancing mitochondrial ATP production through ATP5F1A phosphorylation.
  • TNK2 inhibitors can function as 'mitocans,' selectively inducing mitophagy in cancer cells and offering a targeted therapeutic strategy.

Related Concept Videos

ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
15.1K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.9K
ATP Synthase: Structure01:18

ATP Synthase: Structure

ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
13.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K